EAACI Congress 2023
BackFlash talks on immune-mediated diseases
Sunday 11 Jun, 14:30 PM -
15:30 PM CEST
Hall Y 09+10
Flash Talks
14:30
Updated safety and efficacy of NTLA-2002, a CRISPR/Cas9-based gene editing therapy targeting KLKB1, in a Phase 1 study of patients with hereditary angioedema
14:37
Api m 10 epitope mapping in a mouse model of honeybee venom sensitization
14:44
Exploring the Therapeutic Potential of Probiotic-Derived Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Protein as an Anti-Allergy Agent
